CORZ vs FFIV
Core Scientific, Inc. vs F5, Inc. — AI-powered side-by-side comparison
CORZ
Core Scientific, Inc.
60
Buy
VS
| Metric | CORZ | FFIV |
|---|
| AI Score |
60
|
69
|
| Price |
$19.76
|
$413.92
|
| P/E Ratio |
-4.66×
|
32.60×
|
| ROE |
30.0%
|
19.3%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
28.3%
|
82.2%
|
| Debt / Equity |
-1.78×
|
0.06×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
38.6
|
54.1
|
| Beta |
5.592
|
1.033
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for CORZ versus FFIV.
FFIV leads by 9 points.
FFIV scores 69/100 (Buy) versus CORZ at 60/100 (Buy).
CORZ Committee View
50% agreement
6 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 26.4% yoy -- genuine top-line momentum. Risk Analyst remains cautious — bollinger bandwidth of 28.5% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Price-to-book of 0.3x is a discount to asset value — Value
- Revenue growing 26.4% YoY -- genuine top-line momentum — Growth
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- ROE of only -94.1% -- cheap may mean cheap for a reason — Value
- MACD histogram negative -- bearish momentum — Technical
- Bollinger bandwidth of 28.5% signals elevated volatility — Risk
FFIV Committee View
83% agreement
6 analysts
The primary driver is low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock. The main limiting factor is p/e of 31.6 is moderate-to-rich. The committee is constructive but not yet at full conviction.
Bull Case
- ROE of 19.9% shows genuine earnings power backing the valuation — Value
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- P/E of 31.6 is moderate-to-rich — Value
- Price-to-book of 5.2x prices in significant intangible value — Value